Product Information

RANOLAZINE ER 500 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.1629 per EA under NDC 60687054921. Its NADAC has been published 301 times since Sep 23, 2020.

The Low Outlier badge above means this manufacturer's average price in the Ranolazine market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

RANOLAZINE ER 500 MG TABLET

Ranolazine
$0.1629per EA
Low Outlier

Strength

500 mg/1

NDC

60687054921

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

RANOLAZINE

Approval Type

Generic (ANDA)

FDA Application

ANDA210054

On Market Since

8/19/2020

Pharmacological Classes

Anti-anginal
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for RANOLAZINE ER 500 MG TABLET has been published 301 times since Sep 23, 2020, and over the history we have for it it has declined 62.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1629 per EA
All-time high$0.4370 (Oct 14, 2020)
All-time low$0.1624 (Feb 18, 2026)
52-week high$0.1976
52-week low$0.1624
Median price$0.2336
Average price$0.2540
Largest weekly change+17.6% (Aug 21, 2024)
Weeks tracked301
Tracking sinceSep 23, 2020

Price History

1W

0.0%

1M

-2.9%

3M

-1.6%

6M

-1.4%

1Y

-17.6%

3Y

-23.7%

5Y

-52.1%

All

-62.7%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of RANOLAZINE ER 500 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RANOLAZINE ER 500 MG TABLET, manufactured by American Health Packaging, is $0.1629 per EA (NDC 60687054921), effective Jun 24, 2026.

How has the price of RANOLAZINE ER 500 MG TABLET changed over time?

Over the history we have for it, the NADAC for RANOLAZINE ER 500 MG TABLET has declined 62.7%. It has been tracked across 301 weekly CMS publications since Sep 23, 2020.

What are the highest and lowest recorded NADAC prices for RANOLAZINE ER 500 MG TABLET?

Since Sep 23, 2020, the NADAC for RANOLAZINE ER 500 MG TABLET has ranged from a low of $0.1624 (Feb 18, 2026) to a high of $0.4370 (Oct 14, 2020), with a median of $0.2336 per EA.

Are there cheaper alternatives to RANOLAZINE ER 500 MG TABLET?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RANOLAZINE ER 500 MG TABLET, is $0.1624 per EA — about 0% below RANOLAZINE ER 500 MG TABLET.

Who manufactures RANOLAZINE ER 500 MG TABLET?

RANOLAZINE ER 500 MG TABLET (NDC 60687054921) is labeled by American Health Packaging, and CMS classifies it as a generic product.